Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.

Chapman MA, Sive J, Ambrose J, Roddie C, Counsell N, Lach A, Abbasian M, Popat R, Cavenagh JD, Oakervee H, Streetly MJ, Schey S, Koh M, Willis F, Virchis AE, Crowe J, Quinn MF, Cook G, Crawley CR, Pratt G, Cook M, Braganza N, Adedayo T, Smith P, Clifton-Hadley L, Owen RG, Sonneveld P, Keats JJ, Herrero J, Yong K.

Blood. 2018 Sep 4. pii: blood-2018-05-849893. doi: 10.1182/blood-2018-05-849893. [Epub ahead of print]

PMID:
30181174
2.

Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial).

Popat R, Brown SR, Flanagan L, Hall A, Gregory W, Kishore B, Streetly M, Oakervee H, Yong K, Cook G, Low E, Cavenagh J; Myeloma UK Early Phase Clinical Trial Network.

Br J Haematol. 2018 Aug 20. doi: 10.1111/bjh.15551. [Epub ahead of print] No abstract available.

PMID:
30125960
3.

A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.

Chavda SJ, Maciocia PM, Mesiri P, Counsell N, Kothari J, Bird A, Mariner C, Chew A, Clesham K, Moore S, Percy L, Rismani A, D'Sa S, Rabin N, Popat R, Yong K.

Br J Haematol. 2018 Jul 9. doi: 10.1111/bjh.15487. [Epub ahead of print] No abstract available.

PMID:
29984833
4.

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.

El-Sharkawi D, Ng CH, Payne EM, Yong KL, Ardeshna KM, Khwaja A, Townsend W, Popat R.

Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15457. [Epub ahead of print] No abstract available.

PMID:
29978458
5.

Quality of surgical randomized controlled trials in hand surgery: a systematic review.

Long C, desJardins-Park HE, Popat R, Fox PM.

J Hand Surg Eur Vol. 2018 Oct;43(8):801-807. doi: 10.1177/1753193418780184. Epub 2018 Jun 13.

PMID:
29896997
6.

Optimal Management of Histone Deacetylase Inhibitor-Related Adverse Events in Patients With Multiple Myeloma: A Focus on Panobinostat.

Cavenagh JD, Popat R.

Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):501-507. doi: 10.1016/j.clml.2018.05.007. Epub 2018 May 24. Review.

PMID:
29804873
7.

Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.

Chin M, Sive JI, Allen C, Roddie C, Chavda SJ, Smith D, Blombery P, Jones K, Ryland GL, Popat R, Rismani A, D'Sa S, Rabin N, Gale RE, Yong KL.

Blood Cancer J. 2017 Sep 15;7(9):e610. doi: 10.1038/bcj.2017.76. No abstract available.

8.

Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services.

Popat R, Dowling E, Achhala S, Pandit D, Rabin N, Kyriakou C, Mackinnon S, Yong K, Wechalekar A.

Br J Haematol. 2018 Sep;182(6):936-939. doi: 10.1111/bjh.14897. Epub 2017 Aug 18. No abstract available.

PMID:
28832959
9.

Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A, D'Sa S, Dikaios N, Sokolska M, Antonelli M, Ourselin S, Yong K, Taylor SA, Halligan S, Punwani S.

Eur Radiol. 2017 Dec;27(12):5325-5336. doi: 10.1007/s00330-017-4907-8. Epub 2017 Jun 27.

10.

Diagnostic Utility of Intraoperative Neurophysiological Monitoring for Intramedullary Spinal Cord Tumors: Systematic Review and Meta-Analysis.

Azad TD, Pendharkar AV, Nguyen V, Pan J, Connolly ID, Veeravagu A, Popat R, Ratliff JK, Grant GA.

Clin Spine Surg. 2018 Apr;31(3):112-119. doi: 10.1097/BSD.0000000000000558.

PMID:
28650882
11.

Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.

Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW Jr.

Radiother Oncol. 2017 May;123(2):270-275. doi: 10.1016/j.radonc.2017.03.021. Epub 2017 Apr 28.

PMID:
28460826
12.

Environmental modification via a quorum sensing molecule influences the social landscape of siderophore production.

Popat R, Harrison F, da Silva AC, Easton SA, McNally L, Williams P, Diggle SP.

Proc Biol Sci. 2017 Apr 12;284(1852). pii: 20170200. doi: 10.1098/rspb.2017.0200.

13.

Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.

Maciocia N, Melville A, Cheesman S, Sharpley F, Ramasamy K, Streetly M, Jenner M, Benjamin R, Schey S, Maciocia P, Popat R, D'sa S, Rismani A, Cerner A, Yong K, Rabin N.

Br J Haematol. 2017 Mar;176(6):908-917. doi: 10.1111/bjh.14547. Epub 2017 Feb 17.

PMID:
28211054
14.

Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.

Popat RJ, Hakki S, Thakker A, Coughlan AM, Watson J, Little MA, Spickett CM, Lavender P, Afzali B, Kemper C, Robson MG.

JCI Insight. 2017 Jan 26;2(2):e87379. doi: 10.1172/jci.insight.87379.

15.

Short- to mid-term results of ulna head replacement as both a primary and revision implant.

Baring TK, Popat R, Abdelwahab A, Ferris B.

J Clin Orthop Trauma. 2016 Oct-Dec;7(4):292-295. Epub 2016 Jul 25.

16.

Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.

Popat R, Brown SR, Flanagan L, Hall A, Gregory W, Kishore B, Streetly M, Oakervee H, Yong K, Cook G, Low E, Cavenagh J; Myeloma UK Early Phase Clinical Trial Network.

Lancet Haematol. 2016 Dec;3(12):e572-e580. doi: 10.1016/S2352-3026(16)30165-X. Epub 2016 Nov 12.

17.

Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.

Latifoltojar A, Hall-Craggs M, Rabin N, Popat R, Bainbridge A, Dikaios N, Sokolska M, Rismani A, D'Sa S, Punwani S, Yong K.

Br J Haematol. 2017 Jan;176(2):222-233. doi: 10.1111/bjh.14401. Epub 2016 Oct 21.

18.

Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5.

Freeley SJ, Popat RJ, Parmar K, Kolev M, Hunt BJ, Stover CM, Schwaeble W, Kemper C, Robson MG.

J Pathol. 2016 Sep;240(1):61-71. doi: 10.1002/path.4754.

19.

First Trimester Hemoglobin A1c Prediction of Gestational Diabetes.

Osmundson SS, Zhao BS, Kunz L, Wang E, Popat R, Nimbal VC, Palaniappan LP.

Am J Perinatol. 2016 Aug;33(10):977-82. doi: 10.1055/s-0036-1581055. Epub 2016 Apr 27.

PMID:
27120479
20.

Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.

Reyal Y, Popat R, Cheesman S, Rismani A, D'Sa S, Rabin N, Yong K.

Br J Haematol. 2017 May;177(3):495-497. doi: 10.1111/bjh.14086. Epub 2016 Apr 8. No abstract available.

PMID:
27062387
21.

Beyond killing: Can we find new ways to manage infection?

Vale PF, McNally L, Doeschl-Wilson A, King KC, Popat R, Domingo-Sananes MR, Allen JE, Soares MP, K├╝mmerli R.

Evol Med Public Health. 2016 Apr 18;2016(1):148-57. doi: 10.1093/emph/eow012. Print 2016. Review.

22.

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.

Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW Jr.

Radiat Oncol. 2016 Mar 15;11:40. doi: 10.1186/s13014-016-0616-8.

23.

An Innovative Blended Preclinical Curriculum in Clinical Epidemiology and Biostatistics: Impact on Student Satisfaction and Performance.

Evans KH, Thompson AC, O'Brien C, Bryant M, Basaviah P, Prober C, Popat RA.

Acad Med. 2016 May;91(5):696-700. doi: 10.1097/ACM.0000000000001085.

PMID:
26796089
24.

Quorum sensing protects bacterial co-operation from exploitation by cheats.

Allen RC, McNally L, Popat R, Brown SP.

ISME J. 2016 Jul;10(7):1706-16. doi: 10.1038/ismej.2015.232. Epub 2016 Jan 8.

25.

Factors Associated with Patient Press Ganey Satisfaction Scores for Ophthalmology Patients.

Long C, Tsay EL, Jacobo SA, Popat R, Singh K, Chang RT.

Ophthalmology. 2016 Feb;123(2):242-7. doi: 10.1016/j.ophtha.2015.09.044. Epub 2015 Nov 3.

PMID:
26545321
26.

Craniotomy for Resection of Meningioma: An Age-Stratified Analysis of the MarketScan Longitudinal Database.

Connolly ID, Cole T, Veeravagu A, Popat R, Ratliff J, Li G.

World Neurosurg. 2015 Dec;84(6):1864-70. doi: 10.1016/j.wneu.2015.08.018. Epub 2015 Aug 28.

PMID:
26318633
27.

Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis.

Goldstone AB, Patrick WL, Cohen JE, Aribeana CN, Popat R, Woo YJ.

Ann Cardiothorac Surg. 2015 May;4(3):220-9. doi: 10.3978/j.issn.2225-319X.2015.04.01. Review.

28.

Conflict of interest and signal interference lead to the breakdown of honest signaling.

Popat R, Pollitt EJ, Harrison F, Naghra H, Hong KW, Chan KG, Griffin AS, Williams P, Brown SP, West SA, Diggle SP.

Evolution. 2015 Sep;69(9):2371-83. doi: 10.1111/evo.12751. Epub 2015 Sep 8.

29.

Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors.

Pu J, Zhao B, Wang EJ, Nimbal V, Osmundson S, Kunz L, Popat RA, Chung S, Palaniappan LP.

Paediatr Perinat Epidemiol. 2015 Sep;29(5):436-43. doi: 10.1111/ppe.12209. Epub 2015 Jul 22.

PMID:
26201385
30.

Reliability and Validity of the Pediatric Palliative Care Questionnaire for Measuring Self-Efficacy, Knowledge, and Adequacy of Prior Medical Education among Pediatric Fellows.

Brock KE, Cohen HJ, Popat RA, Halamek LP.

J Palliat Med. 2015 Oct;18(10):842-8. doi: 10.1089/jpm.2015.0110. Epub 2015 Jul 17.

31.

Live Video Diet and Exercise Intervention in Overweight and Obese Youth: Adherence and Cardiovascular Health.

Nourse SE, Olson I, Popat RA, Stauffer KJ, Vu CN, Berry S, Kazmucha J, Ogareva O, Couch SC, Urbina EM, Tierney ES.

J Pediatr. 2015 Sep;167(3):533-9.e1. doi: 10.1016/j.jpeds.2015.06.015. Epub 2015 Jul 4.

PMID:
26154402
32.

Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.

Van Den Eeden SK, Albers KB, Davidson JE, Kushida CA, Leimpeter AD, Nelson LM, Popat R, Tanner CM, Bibeau K, Quesenberry CP.

Sleep. 2015 Jul 1;38(7):1009-15. doi: 10.5665/sleep.4800.

33.

Factors associated with delays to surgical presentation in North-West Cameroon.

Long C, Titus Ngwa Tagang E, Popat RA, Lawong EK, Brown JA, Wren SM.

Surgery. 2015 Sep;158(3):756-63. doi: 10.1016/j.surg.2015.04.016. Epub 2015 Jun 9.

PMID:
26067462
34.

Collective sensing and collective responses in quorum-sensing bacteria.

Popat R, Cornforth DM, McNally L, Brown SP.

J R Soc Interface. 2015 Feb 6;12(103). pii: 20140882. doi: 10.1098/rsif.2014.0882. Review.

35.

Genomic characterisation of an endometrial pathogenic Escherichia coli strain reveals the acquisition of genetic elements associated with extra-intestinal pathogenicity.

Goldstone RJ, Popat R, Schuberth HJ, Sandra O, Sheldon IM, Smith DG.

BMC Genomics. 2014 Dec 6;15:1075. doi: 10.1186/1471-2164-15-1075.

36.

Complement and glomerular diseases.

Popat RJ, Robson MG.

Nephron Clin Pract. 2014;128(3-4):238-42. doi: 10.1159/000368591. Epub 2014 Nov 19. Review.

37.

An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma.

Popat R, Khan I, Dickson J, Cheesman S, Smith D, D'Sa S, Rabin N, Yong K.

Br J Haematol. 2015 Jan;168(1):148-51. doi: 10.1111/bjh.13072. Epub 2014 Aug 8. No abstract available.

PMID:
25103844
38.

Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.

Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW Jr.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):216-23. doi: 10.1016/j.ijrobp.2014.05.025. Epub 2014 Jul 8.

PMID:
25015205
39.

Oral surgery: ARONJ masterclass.

Moore A, Renton T, Taylor T, Popat S, Popat R, Sivardeen Z, Fogelman I, Hawkesford A, Ruggiero S, Rogers S, Leyland S, Coleman R.

Br Dent J. 2014 May;216(9):488-9. doi: 10.1038/sj.bdj.2014.360. No abstract available. Erratum in: Br Dent J. 2014 May;216(10):565. Moore, A [added].

PMID:
24809547
40.

Combinatorial communication in bacteria: implications for the origins of linguistic generativity.

Scott-Phillips TC, Gurney J, Ivens A, Diggle SP, Popat R.

PLoS One. 2014 Apr 23;9(4):e95929. doi: 10.1371/journal.pone.0095929. eCollection 2014.

41.

Arterial applanation tonometry: feasibility and reproducibility in children and adolescents.

Lowenthal A, Evans JM, Punn R, Nourse SE, Vu CN, Popat RA, Selamet Tierney ES.

Am J Hypertens. 2014 Sep;27(9):1218-24. doi: 10.1093/ajh/hpu034. Epub 2014 Mar 13.

42.

Targeting virulence: can we make evolution-proof drugs?

Allen RC, Popat R, Diggle SP, Brown SP.

Nat Rev Microbiol. 2014 Apr;12(4):300-8. doi: 10.1038/nrmicro3232. Review.

PMID:
24625893
43.

Combinatorial quorum sensing allows bacteria to resolve their social and physical environment.

Cornforth DM, Popat R, McNally L, Gurney J, Scott-Phillips TC, Ivens A, Diggle SP, Brown SP.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4280-4. doi: 10.1073/pnas.1319175111. Epub 2014 Mar 4.

44.

Outcome and cost analysis of induction immunosuppression with IL2Mab or ATG in DCD kidney transplants.

Popat R, Syed A, Puliatti C, Cacciola R.

Transplantation. 2014 Jun 15;97(11):1161-5. doi: 10.1097/01.tp.0000442505.10490.20.

PMID:
24573113
45.

Loss of social behaviours in populations of Pseudomonas aeruginosa infecting lungs of patients with cystic fibrosis.

Jiricny N, Molin S, Foster K, Diggle SP, Scanlan PD, Ghoul M, Johansen HK, Santorelli LA, Popat R, West SA, Griffin AS.

PLoS One. 2014 Jan 14;9(1):e83124. doi: 10.1371/journal.pone.0083124. eCollection 2014.

46.

Current uses of smartphones and apps in orthopaedic surgery.

Popat R, Mohan AT, Branford OA.

Br J Hosp Med (Lond). 2013 Dec;74(12):672-6. Review. No abstract available.

PMID:
24326713
47.

Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice.

Freeley SJ, Giorgini A, Tulone C, Popat RJ, Horsfield C, Robson MG.

PLoS One. 2013 Sep 24;8(9):e74112. doi: 10.1371/journal.pone.0074112. eCollection 2013.

48.

The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models.

Maharaj L, Marson CM, Middleton BJ, Rioja AS, Perry J, Oakervee H, Cavenagh J, Joel SP, Popat R.

Br J Haematol. 2013 Oct;163(1):135-9. doi: 10.1111/bjh.12456. Epub 2013 Jul 9. No abstract available.

PMID:
23834265
49.

Evaluation and analysis of noise levels at traffic intersections of Nagpur city, India.

Vijay R, Popat R, Pisode M, Sharma A, Manoj K, Chakrabarti T, Gupta R.

J Environ Sci Eng. 2013 Apr;55(2):197-206.

PMID:
25464696
50.

Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.

Marina N, Hudson MM, Jones KE, Mulrooney DA, Avedian R, Donaldson SS, Popat R, West DW, Fisher P, Leisenring W, Stovall M, Robison LL, Ness KK.

Arch Phys Med Rehabil. 2013 Jun;94(6):1062-73. doi: 10.1016/j.apmr.2013.01.013. Epub 2013 Feb 1.

Supplemental Content

Support Center